Publicacións en colaboración con investigadores/as de University of Cagliari (34)

2020

  1. Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists

    Journal of Medicinal Chemistry, Vol. 63, Núm. 5, pp. 2577-2587

2019

  1. Antibacterial Activity and Molecular Docking Studies of a Selected Series of Hydroxy-3-arylcoumarins

    Molecules (Basel, Switzerland), Vol. 24, Núm. 15

2018

  1. Coumarin derivatives as promising xanthine oxidase inhibitors

    International Journal of Biological Macromolecules, Vol. 120, pp. 1286-1293

  2. Evaluation of trypanocidal and antioxidant activities of a selected series of 3-amidocoumarins

    Medicinal Chemistry, Vol. 14, Núm. 6, pp. 573-584

  3. Targeting α -(1,4)-glucosidase in diabetes mellitus type 2: The role of new synthetic coumarins as potent inhibitors

    Current Topics in Medicinal Chemistry, Vol. 18, Núm. 27, pp. 2327-2337

2017

  1. New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies

    Bioorganic and Medicinal Chemistry, Vol. 25, Núm. 5, pp. 1687-1695

2016

  1. Progress in the development of small molecules as new human A3 adenosine receptor ligands based on the 3-thiophenylcoumarin core

    MedChemComm, Vol. 7, Núm. 5, pp. 845-852

2015

  1. Design and discovery of tyrosinase inhibitors based on a coumarin scaffold

    RSC Advances, Vol. 5, Núm. 114, pp. 94227-94235

2013

  1. MAO Inhibitory Activity of 2-Arylbenzofurans versus 3-Arylcoumarins: Synthesis, invitro Study, and Docking Calculations

    ChemMedChem, Vol. 8, Núm. 6, pp. 956-966

2012

  1. 8-Substituted 3-Arylcoumarins as Potent and Selective MAO-B Inhibitors: Synthesis, Pharmacological Evaluation, and Docking Studies

    ChemMedChem, Vol. 7, Núm. 3, pp. 464-470

  2. Antitrypanosomal and antioxidant properties of 4-hydroxycoumarins derivatives

    Bioorganic and Medicinal Chemistry Letters, Vol. 22, Núm. 17, pp. 5569-5573

  3. Erratum: Synthesis and cytotoxic activity of non-naturally substituted 4-oxycoumarin derivatives (Bioorganic and Medicinal Chemistry Letters (2012) 22 (5791-5794))

    Bioorganic and Medicinal Chemistry Letters

  4. Hydroxycoumarins as selective MAO-B inhibitors

    Bioorganic and Medicinal Chemistry Letters, Vol. 22, Núm. 1, pp. 258-261

  5. Predicting monoamine oxidase inhibitory activity through ligand-based models

    Current Topics in Medicinal Chemistry, Vol. 12, Núm. 20, pp. 2258-2274

  6. Synthesis and cytotoxic activity of non-naturally substituted 4-oxycoumarin derivatives

    Bioorganic and Medicinal Chemistry Letters, Vol. 22, Núm. 18, pp. 5791-5794

  7. Tyrosine-like condensed derivatives as tyrosinase inhibitors

    Journal of Pharmacy and Pharmacology, Vol. 64, Núm. 5, pp. 742-746

2011

  1. New halogenated phenylcoumarins as tyrosinase inhibitors

    Bioorganic and Medicinal Chemistry Letters, Vol. 21, Núm. 11, pp. 3342-3345

2010

  1. Regioselective synthesis of bromo-substituted 3-arylcoumarins

    Synthesis, pp. 2763-2766

  2. Synthesis and vasorelaxant and platelet antiaggregatory activities of a new series of 6-Halo-3-phenylcoumarins

    Molecules, Vol. 15, Núm. 1, pp. 270-279

  3. Synthesis of carbocyclic pyrimidine nucleosides using the Mitsunobu reaction: O2- vs. N1-alkylation

    Helvetica Chimica Acta, Vol. 93, Núm. 2, pp. 309-313